Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC
SAN ANTONIO -- Two trials of neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) produced mixed efficacy signals. The NSABP B-59/GBG-96-GeparDouze ...